THE BRITISH SOCIETY FOR HAEMATOLOGY
Financial health, per its FY2025 accounts
The accounts state that the charity holds substantial unrestricted reserves of £12,061,368, significantly exceeding its stated operational reserve policy target of £2,550,000. The trustees confirm that these resources are adequate to continue operations for the short and medium term, with no material uncertainties identified regarding going concern. The charity reported a net decrease in total funds of £11,492 for the year, driven by investment losses and designated fund expenditures, while maintaining a strong cash and investment position.
What the accounts disclose
“There was 1 employee whose emoluments for the year were between £80,000 - £90,000 (2024:0).” — page 25
“There was 1 employee whose emoluments for the year were between £80,000 - £90,000 (2024:0).” — page 25
“An allowance of 20% for market volatility was agreed, resulting in an Operational Reserve figure of £2,550,000. In addition, there should be a cash reserve of £500,000 at the year end to maintain fluidity” — page 14
“The charity wholly owns its trading subsidiary, BSH Enterprises Limited (BSHE), through which the organisation of the Annual Scientific Meeting (ASM) for the British Society for Haematology is conducted.” — page 15
Corporate structure
- Registered company of the charity Companies House 02645706
- Trading subsidiary: BSH ENTERPRISES LIMITED Companies House 02677826
Leadership, per the charity’s website
- Dr John Ashcroft — President
- Carol Bewick — CEO
- Professor Gordon Cook — Vice President
- Huw Rowswell — Treasurer
- Professor Guy Pratt — Secretary
Structured financials (annual return, FY ending 30/09/2025)
Register events
- Received assets from another charity (12/01/2024)
Trustees
- DR JOHN ASHCROFT
- David Patrick Keefe
- Dr Cathy Burton
- Dr Christopher Dalley
- Dr Fiona Mary Miall
- Dr John Andrew Snowden
- Dr Shankaranarayana Paneesha
- Huw Rowswell
- KEITH WARD
- Kate Ellen Fielding
- Laura Miller
- Prof Gordon Cook
- Professor Adam Mead
- Professor Guy Pratt
- Professor Keith Gomez
- Tharindi Hapuarachchi
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £3.3m | £3.2m |
| 30/09/2024 | £3.3m | £3.1m |
| 30/09/2023 | £2.8m | £2.6m |
| 30/09/2022 | £2.6m | £2.5m |
| 30/09/2021 | £2.8m | £1.9m |
Common questions
Is THE BRITISH SOCIETY FOR HAEMATOLOGY financially healthy?
The accounts state that the charity holds substantial unrestricted reserves of £12,061,368, significantly exceeding its stated operational reserve policy target of £2,550,000. The trustees confirm that these resources are adequate to continue operations for the short and medium term, with no material uncertainties identified regarding going concern. The charity reported a net decrease in total funds of £11,492 for the year, driven by investment losses and designated fund expenditures, while maintaining a strong cash and investment position. Its FY2025 accounts were audited by Haysmacintyre LLP.
What does the highest-paid employee of THE BRITISH SOCIETY FOR HAEMATOLOGY earn?
Per its FY2025 accounts, the highest-paid employee was in the £80,001 - £90,000 band, and 1 employees earned over £60,000.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE COMPANY OF BIOLOGISTS | 1 | £140k |
| THE BARBERS' COMPANY GENERAL CHARITIES | 1 | £1k |